Global 3D Bioprinting Market 2014-2018: Key Vendors are 3D Systems, EnvisionTEC, Organovo Holdings and Stratasys

DUBLIN, Sept. 19, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global 3D Bioprinting Market 2014-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

3D bioprinting is a process to produce tissues in a variety of formats from micro-scale tissues to standard multi-well tissues, where cell function and viability are preserved within the printed construct. A 3D bioprinter is a medical device used to regenerate human tissues, which are created by human cells.

The 3D micro-engineered environments open new channels for drug screening and fundamental studies of wound healing, angiogenesis, and stem-cell niches. Many industries have already benefitted from multiple advancements in this field, resulting in improved and more efficient processes worldwide.

The analysts forecast the Global 3D Bioprinting market to grow at a CAGR of 14.52 percent over the period 2013-2018.

The Global 3D Bioprinting market can be segmented into the technology available in the market: Ink-jet Bioprinters, Valve-based Cell Printers, Laser-assisted Cell Printers, and Magnetic Levitation Bioprinters.

The report, the Global 3D Bioprinting Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global 3D Bioprinting market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The Global 3D Bioprinting market shows immense potential to grow rapidly in the future, mainly because of the advances in technology of the product. Technological advancements and innovations in the Healthcare industry have resulted in the development of equipment with up-to-date technology that is customized to the needs of patients.

According to the report, growing demand from the drug discovery process is one of the major drivers in the market. The use of 3D bioprinting reduces the risk of drug failure during pre-clinical trial testing and minimizes the complications related to human trials.

Further, the report states that one of the major challenges in the market is the high price of 3D bioprinting surgeries. The high cost of 3D printing lowers its acceptance among end-users. In addition, there is no healthcare support for 3D printing surgery, which makes it very difficult for many patients to opt for it.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Technology

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

17. Key Vendor Analysis

Companies Mentioned:

• 3D Systems
• EnvisionTEC
• Organovo Holdings
• Stratasys
• 3D Biotek
• Advanced Biomatrix
• Bespoke Innovations
• Digilab
• regenHU
• Nano3D Biosciences

For more information visit http://www.researchandmarkets.com/research/6rmjlz/global_3d

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net